Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome

Anderman, 1991, Chronic encephalitis and epilepsy: an overview, 283 Bauer, 2007, Astrocytes are a specific immunological target in Rasmussen's encephalitis, Ann. Neurol., 62, 67, 10.1002/ana.21148 Bien, 2002, Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis, Ann. Neurol., 51, 311, 10.1002/ana.10100 Bien, 2002, Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology, Neurology, 58, 250, 10.1212/WNL.58.2.250 Bien, 2005, Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement, Brain, 128, 454, 10.1093/brain/awh415 Dalmau, 2007, Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma, Ann. Neurol., 61, 25, 10.1002/ana.21050 Dalmau, 2008, Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, Lancet Neurol., 7, 1091, 10.1016/S1474-4422(08)70224-2 Dalmau, 2011, Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis, Lancet Neurol., 10, 63, 10.1016/S1474-4422(10)70253-2 Farrell, 1995, Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies, Acta Neuropathol., 89, 313, 10.1007/BF00309624 Florance, 2009, Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents, Ann. Neurol., 66, 11, 10.1002/ana.21756 Fujita, 2012, Antibodies to N-methyl-d-aspartate glutamate receptors in Creutzfeldt–Jakob disease patients, J. Neuroimmunol., 251, 90, 10.1016/j.jneuroim.2012.06.010 Gahring, 2001, Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated byglycosylation, J. Immunol., 166, 1433, 10.4049/jimmunol.166.3.1433 Ganor, 2005, Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA, Epilepsy Res., 65, 11, 10.1016/j.eplepsyres.2005.03.011 Hughes, 2010, Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis, J. Neurosci., 30, 5866, 10.1523/JNEUROSCI.0167-10.2010 Irani, 2010, N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes, Brain, 133, 1655, 10.1093/brain/awq113 Lau, 2007, NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders, Nat. Rev. Neurosci., 8, 413, 10.1038/nrn2153 Mori, 1998, Role of the carboxy-terminal region of the GluR epsilon2 subunit in synaptic localization of the NMDA receptor channel, Neuron, 21, 571, 10.1016/S0896-6273(00)80567-X Niehusmann, 2009, Diagnostic value of N-methyl-d-aspartate receptor antibodies in women with new-onset epilepsy, Arch. Neurol., 66, 458, 10.1001/archneurol.2009.5 Oguni, 1992, The syndrome of chronic encephalitis and epilepsy. A study based on the MNI series of 48 cases, Adv. Neurol., 57, 419 Rasmussen, 1958, Focal seizures due to chronic localized encephalitis, Neurology, 8, 435, 10.1212/WNL.8.6.435 Rasmussen, 1978, Further observations on the syndrome of chronic encephalitis and epilepsy, Appl. Neurophysiol., 41, 1 Rogers, 1994, Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis, Science, 265, 648, 10.1126/science.8036512 Suleiman, 2013, Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies, Epilepsia, 54, 2091, 10.1111/epi.12405 Takahashi, 2003, Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua, Neurology, 61, 891, 10.1212/01.WNL.0000086819.53078.70 Takahashi, 2005, Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua, Epilepsia, 46, 152, 10.1111/j.1528-1167.2005.01024.x Takahashi, 2008, Epitope of autoantibodies to N-methyl-d-aspartate receptor heteromers in paraneoplastic limbic encephalitis, Ann. Neurol., 64, 110, 10.1002/ana.21362 Takahashi, 2009, A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNFalpha, and Granzyme B in CSF, Epilepsia, 50, 1419, 10.1111/j.1528-1167.2008.01977.x Takahashi, 2013, Immunomodulatory therapy versus surgery for Rasmussen syndrome in early childhood, Brain Dev., 35, 778, 10.1016/j.braindev.2013.01.010 Takano, 2011, Detection of autoantibody against extracellular epitopes of N-methyl-d-aspartate receptor by cell-based assay, Neurosci. Res., 71, 294, 10.1016/j.neures.2011.07.1834 Watson, 2004, Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis, Neurology, 13, 43, 10.1212/01.WNL.0000132651.66689.0F Watson, 2005, Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis, Neurology, 65, 1802, 10.1212/01.wnl.0000191566.86977.04 Wiendl, 2001, GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis, Neurology, 57, 1511, 10.1212/WNL.57.8.1511 Yang, 2000, Autoimmunity to munc-18 in Rasmussen's encephalitis, Neuron, 28, 375, 10.1016/S0896-6273(00)00118-5